- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/38 - One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
Patent holdings for IPC class C07D 233/38
Total number of patents in this class: 40
10-year publication summary
|
3
|
6
|
5
|
5
|
0
|
3
|
2
|
0
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 186 |
6 |
| Novartis AG | 10345 |
3 |
| Romark Laboratories L.C. | 46 |
3 |
| Enyo Pharma | 54 |
3 |
| National Institute of Biological Sciences, Beijing | 100 |
2 |
| Janssen Biopharma, Inc. | 32 |
2 |
| Orixa Therapeutics LLC | 2 |
2 |
| Bristol-myers Squibb Company | 4812 |
1 |
| F. Hoffmann-La Roche AG | 7839 |
1 |
| E. I. du Pont de Nemours and Company | 3668 |
1 |
| Janssen Pharmaceutica N.V. | 3234 |
1 |
| Wyeth LLC | 613 |
1 |
| FUJIFILM Corporation | 30277 |
1 |
| Henkel AG & Co. KGaA | 10711 |
1 |
| ACS Dobfar S.p.A. | 28 |
1 |
| Acturum Life Science AB | 7 |
1 |
| Central Glass Company, Limited | 1286 |
1 |
| Forma Therapeutics, Inc. | 155 |
1 |
| FUZIANS BIOMEDICALS, Inc. | 1 |
1 |
| Irm LLC | 138 |
1 |
| Other owners | 6 |